KKS’s plasma kallikrein (KK), derived from plasma prekallikrein, can interact with Par1 AND Par2, further aggravating inflammation and potentially contributing to MS pathology (Figure 8A). This evidence concerns the gene F2RL1 and myeloid sarcoma.